Hongsheng Capital Solely Leads Series A Financing Round in Warrenwell to Advance Core Smart Logistics Technologies for Medical and Industrial Automation

June 18, 2025Suzhou Warrenwell HI-TECH CO,LTD (hereinafter referred to as “Warrenwell”) announced the completion of its Series A financing round, which was exclusively invested by Ariose Capital.

Founded in 2012 at the Medical Device Industrial Park in Suzhou New District, Warrenwell boasts a modern integrated office and production center spanning over 30,000 square meters. As a high-tech enterprise focused on developing core technologies with independent intellectual property rights, Warrenwell continuously empowers its core customers in hospitals, libraries, environmental protection, and industrial sectors to achieve intelligent and automated logistics systems.

Warrenwell was founded by senior executives from leading listed companies in China’s domestic industries. The Group owns two well-known industry brands, “Warrenwell” and “Deliefu,” and has established a comprehensive management system and organizational structure. With an international executive team and an industry-leading technical team, Warrenwell is committed to providing customized smart logistics solutions for its core customers.

As a national high-tech enterprise, a founding council member of the Provincial Medical Device Industry Technology Innovation Center, and a municipal-level “Specialized, Refined, Differential, and Innovative” (SRDI) demonstration enterprise, Warrenwell actively assumes the responsibilities of an industry leader and has successfully established the Jiangsu Provincial Engineering Technology Research Center for Intelligent Rail Logistics Transmission Systems.

The Group places great emphasis on the research and development of core technologies, holding over 100 independent intellectual property rights. It has mastered world-leading logistics technologies, including photoelectric positioning device technology, graphite-based communication transmission material technology, and high-robustness intelligent algorithms. The Group led the formulation of the industry standard for “Intelligent Rail Logistics Transmission Systems,” which was approved and certified by the Ministry of Industry and Information Technology of China. Its related product R&D was awarded the title of “National Torch Program Industrialization Project” by the Ministry of Science and Technology of China, successfully passed the national evaluation of scientific and technological achievements, and reached an internationally advanced level overall. The Group’s two major brands serve nearly 1,000 domestic users across all provincial-level administrative regions in China, enjoying a strong brand reputation. Since its establishment, Suzhou Warrenwell HI-TECH CO,LTD has been committed to promoting high-quality and sustainable development in the industry, serving as an industry leader, innovator, and pioneer.

In the healthcare sector, Warrenwell Group continuously refines its comprehensive smart hospital logistics solutions, gradually establishing a portfolio that encompasses intelligent rail logistics systems (TELESYS/MULTILIFT), intelligent bin-based logistics systems (TETRIS/UNIBOX), intelligent pneumatic tube logistics systems (AIRSYS/UNITUBE), automated waste and linen power-assisted retrieval systems (MARIO/UNIDROP), intelligent robotic logistics systems (AXLE/UNIVAN), and low-altitude drone logistics systems (UNIDRONE). It is one of the few professional service providers in China capable of delivering integrated logistics solutions featuring all these systems simultaneously.

Since its establishment, Warrenwell has continuously optimized and enhanced service quality while iteratively upgrading its core products. As the leading enterprise in the niche sector of smart hospital logistics, it has achieved a domestic leading position in terms of technological advancement, brand recognition, and customer satisfaction. Its representative clients include Zhongshan Hospital Fudan University, Ruijin Hospital Shanghai Jiao Tong University School of Medicine, The First Affiliated Hospital Zhejiang University School of Medicine, The First Affiliated Hospital Sun Yat-sen University, Shenzhen Hospital of Cancer Hospital Chinese Academy of Medical Sciences, and The University of Hong Kong-Shenzhen Hospital, among other top-tier hospitals in China.

Furthermore, Warrenwell Group actively addresses the genuine needs of core hospital clients by developing distinctive, competitive products and solutions tailored to essential scenarios such as operating rooms and pharmacies. These offerings have been successfully implemented in numerous top-tier hospitals, earning high recognition from both hospital management and clinical teams.

First is Warrenwell’s intelligent solution for operating rooms and ICUs, specifically including the medical pendant system (GALAXIS), electric surgical table (MEGATRON), and surgical shadowless lamp (SEIRIOS);

Second, Warrenwell Hospital’s automated pharmacy solutions, which specifically include an intelligent rapid dispensing system for outpatient pharmacies, an intelligent management system for controlled substances, an intelligent medication management system for hospital wards, and an intelligent management system for high-value consumables. The company has a thorough understanding of hospital management practices and genuine clinical needs in China, continuously building a competitive product portfolio around its core technologies to deliver superior products and service experiences to hospital clients. Representative clients include West China Hospital of Sichuan University and the Shanghai Geriatric Medical Center.

In the library sector, Warrenwell Group’s product portfolio encompasses intelligent book return systems, automated sorting systems, intelligent rail transport systems, and high-density smart storage systems. These solutions can be customized in various configurations to meet users’ specific needs, adopting an integrated design philosophy that covers self-service book returns, three-dimensional sorting, logistics transmission, and warehousing. This approach maximizes the enhancement of patrons’ service experience—such as reducing return times and offering multiple return options—while ensuring smooth and efficient library workflows and freeing up more workspace for both staff and patrons. Representative clients include top-tier libraries in China, such as the National Library of China, the Shanghai Library East Branch (the largest public library among global world-class cities), the Shenzhen Campus Library of Sun Yat-sen University, and the Changfeng Branch of the Shanghai Children’s Library.

In the industrial sector, Warrenwell Group leverages its core technological strengths to create more customized combinations around its product portfolio, with the potential to unlock a wider range of application scenarios. Its industrial customized solution products include various intelligent heavy-duty logistics transmission systems (APOLLO, SOYUZ) and multiple intelligent rail-based logistics transmission systems (TELESYS GD, 13S, HDL), catering to diverse industrial needs at different levels. The company’s solutions boast numerous performance advantages, such as ultra-high load capacity, intelligence, modularity, flexibility, and efficiency. Surpassing traditional rail-based logistics technologies, they represent cutting-edge technology in this field and are well-suited to meet the complex and variable material handling requirements of industrial environments. The Group is committed to becoming a strategic partner for physical enterprises in high-end manufacturing, new energy, food processing, and other industrial sectors, continuously providing tailored logistics solutions to support their high-quality development.

As the proportion of domestically produced products increases, product R&D iterations accelerate, and innovative products continue to be launched and implemented, Warrenwell Group’s competitive and cost-effective products are gradually expanding into international markets. Since 2023, Warrenwell Group has entered the global market, successfully establishing collaborative projects in Western Europe, Eastern Europe, and Asia. Meanwhile, the company is actively engaging in exchanges and communications with potential partners in other international regions.

Upon the completion of this financing round, the Company will continue to strengthen its technology platform construction and accelerate the integration and application of new quality productive forces—such as automated control, large AI models, and intelligent robotics—with its existing service systems and application scenarios. Actively responding to national strategic initiatives, including the transformation of high-end manufacturing and the development of the low-altitude economy, the Company aims to further optimize and enhance customer service efficiency, delivering smarter and more convenient product and service experiences to its partners. Meanwhile, leveraging the strong industrial and commercialization resources of its founding team and shareholders, the Company will continue to build on its core technological advantages, persistently exploring high-value medical and industrial application scenarios to serve and drive the optimization, upgrading, and high-quality transformation of related downstream industries in China.

Warrenwell stated:Suzhou Warrenwell HI-TECH CO,LTD is committed to its mission of “advancing healthcare through technological innovation and improving human well-being through medical development.” By persistently driving innovation, the company continuously enhances its core competitiveness, deeply integrates emerging technologies with advanced manufacturing, and strives to assist customers in achieving their visionary goals. We extend our gratitude to Ariose Capital Management Limited for its exclusive strategic investment in the company, which signifies a high level of recognition for our team and future prospects. Through this round of financing, Warrenwell will bolster its financial strength and leverage shareholder resources. The company will further upgrade its technology platforms and production facilities, integrating cutting-edge domestic and international technical methods to continuously improve R&D and production efficiency. Warrenwell will accelerate the industrialization of its independently owned core logistics technologies, actively explore collaborations with top-tier enterprises both domestically and internationally, and combine independent R&D with external partnerships. By actively developing new quality productive forces that integrate internationally leading AI large models and intelligent robotics, the company aims to jointly promote the growth and development of China’s smart logistics and industrial automation industries.

Ariose Capital stated:Suzhou Warrenwell HI-TECH CO,LTD is a representative enterprise of new-quality productive forces in China’s medical technology and industrial automation sectors. We highly recognize the significant technical barriers and extensive service expertise that the Group has accumulated through years of deep industry engagement, as well as the founding team’s diligent work ethic and global vision. We are highly optimistic about the trend of leveraging cutting-edge automation technologies to empower traditional industries with upgraded efficiency. Against the backdrop of growing global demand for intelligence and automation across various sectors, we believe that Warrenwell can effectively leverage its core strengths in technology and services to continuously empower top-tier partners in the medical and industrial fields, thereby helping to realize greater end-user value. In the future, Ariose Capital Management Limited looks forward to comprehensive cooperation with Warrenwell in the vast blue-ocean markets of medical technology and industrial automation.

Ariose Capital focuses on equity investments in the healthcare and medical sector. Its core limited partners include more than ten publicly listed healthcare companies, state-owned enterprises, market-oriented fund-of-funds, and local governments. Distinguished by its “ecosystem investment strategy” and “comprehensive post-investment value-added services,” Ariose Capital leverages the advantageous resources of industry-listed companies and its team to build a comprehensive health industry ecosystem, while making deep investment arrangements closely aligned with ecosystem resources. Meanwhile, it fully utilizes these ecosystem resources to provide a series of post-investment value-added services to portfolio companies, facilitating their robust development and delivering superior returns to the fund’s investors.